List of Tables
    Table 1. Global Human Immunoglobulin for Intravenous Injection Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Children
    Table 3. Major Manufacturers of Adult
    Table 4. Global Human Immunoglobulin for Intravenous Injection Market Size Growth Rate by Application (2021-2027) & (K Units)
    Table 5. Global Human Immunoglobulin for Intravenous Injection Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
    Table 6. Global Human Immunoglobulin for Intravenous Injection Sales by Regions (2016-2021) & (K Units)
    Table 7. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Regions (2016-2021)
    Table 8. Global Human Immunoglobulin for Intravenous Injection Revenue by Regions (2016-2021) & (US$ Million)
    Table 9. Global Human Immunoglobulin for Intravenous Injection Sales Forecast by Region (2022-2027) & (K Units)
    Table 10. Global Human Immunoglobulin for Intravenous Injection Sales Market Share Forecast by Region (2022-2027)
    Table 11. Global Human Immunoglobulin for Intravenous Injection Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 12. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share Forecast by Region (2022-2027)
    Table 13. Global Human Immunoglobulin for Intravenous Injection Sales by Manufacturers (2016-2021) (K Units)
    Table 14. Global Human Immunoglobulin for Intravenous Injection Sales Share by Manufacturers (2016-2021)
    Table 15. Ranking of Global Top Human Immunoglobulin for Intravenous Injection Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Human Immunoglobulin for Intravenous Injection Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 17. Human Immunoglobulin for Intravenous Injection Revenue Share by Manufacturers (2016-2021)
    Table 18. Global Human Immunoglobulin for Intravenous Injection Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 19. Global Human Immunoglobulin for Intravenous Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immunoglobulin for Intravenous Injection as of 2020)
    Table 20. Key Manufacturers Human Immunoglobulin for Intravenous Injection Price (2016-2021) (US$/Unit)
    Table 21. Human Immunoglobulin for Intravenous Injection Manufacturers Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Human Immunoglobulin for Intravenous Injection Product Type
    Table 23. Date of International Manufacturers Enter into Human Immunoglobulin for Intravenous Injection Market
    Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 25. Global Human Immunoglobulin for Intravenous Injection Sales by Type (2016-2021) (K Units)
    Table 26. Global Human Immunoglobulin for Intravenous Injection Sales Share by Type (2016-2021)
    Table 27. Global Human Immunoglobulin for Intravenous Injection Revenue by Type (2016-2021) (US$ Million)
    Table 28. Global Human Immunoglobulin for Intravenous Injection Revenue Share by Type (2016-2021)
    Table 29. Human Immunoglobulin for Intravenous Injection Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
    Table 30. Global Human Immunoglobulin for Intravenous Injection Sales Forecast by Type (2022-2027) & (K Units)
    Table 31. Global Human Immunoglobulin for Intravenous Injection Sales Market Share Forecast by Type (2022-2027)
    Table 32. Global Human Immunoglobulin for Intravenous Injection Revenue Forecast V (2022-2027) & (US$ Million)
    Table 33. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share Forecast by Type (2022-2027)
    Table 34. Global Human Immunoglobulin for Intravenous Injection Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
    Table 35. Global Human Immunoglobulin for Intravenous Injection Sales by Application (2016-2021) (K Units)
    Table 36. Global Human Immunoglobulin for Intravenous Injection Sales Share by Application (2016-2021)
    Table 37. Global Human Immunoglobulin for Intravenous Injection Revenue by Application (2016-2021) (US$ Million)
    Table 38. Global Human Immunoglobulin for Intravenous Injection Revenue Share by Application (2016-2021)
    Table 39. Human Immunoglobulin for Intravenous Injection Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
    Table 40. Global Human Immunoglobulin for Intravenous Injection Sales Forecast by Application (2022-2027) & (K Units)
    Table 41. Global Human Immunoglobulin for Intravenous Injection Sales Market Share Forecast by Application (2022-2027)
    Table 42. Global Human Immunoglobulin for Intravenous Injection Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 43. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share Forecast by Application (2022-2027)
    Table 44. Global Human Immunoglobulin for Intravenous Injection Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
    Table 45. Japan Human Immunoglobulin for Intravenous Injection Sales (K Units) of Key Companies (2016-2021)
    Table 46. Japan Human Immunoglobulin for Intravenous Injection Sales Share by Company (2016-2021)
    Table 47. Japan Human Immunoglobulin for Intravenous Injection Revenue (US$ Million) by Company (2016-2021)
    Table 48. Japan Human Immunoglobulin for Intravenous Injection Revenue Share by Company (2016-2021)
    Table 49. Japan Human Immunoglobulin for Intravenous Injection Sales (K Units) by Type (2016-2021)
    Table 50. Japan Human Immunoglobulin for Intravenous Injection Sales Share by Type (2016-2021)
    Table 51. Japan Human Immunoglobulin for Intravenous Injection Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 52. Japan Human Immunoglobulin for Intravenous Injection Price (US$/Unit) by Type (2016-2021)
    Table 53. Japan Human Immunoglobulin for Intravenous Injection Sales (K Units) by Type (2022-2027)
    Table 54. Japan Human Immunoglobulin for Intravenous Injection Sales Share by Type (2022-2027)
    Table 55. Japan Human Immunoglobulin for Intravenous Injection Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 56. Japan Human Immunoglobulin for Intravenous Injection Revenue Share by Type (2022-2027)
    Table 57. Japan Human Immunoglobulin for Intravenous Injection Price (US$/Unit) by Type (2022-2027)
    Table 58. Japan Human Immunoglobulin for Intravenous Injection Sales (K Units) by Application (2016-2021)
    Table 59. Japan Human Immunoglobulin for Intravenous Injection Sales Share by Application (2016-2021)
    Table 60. Japan Human Immunoglobulin for Intravenous Injection Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 61. Japan Human Immunoglobulin for Intravenous Injection Price (US$/Unit) by Application (2016-2021)
    Table 62. Japan Human Immunoglobulin for Intravenous Injection Sales (K Units) by Application (2022-2027)
    Table 63. Japan Human Immunoglobulin for Intravenous Injection Sales Share by Application (2022-2027)
    Table 64. Japan Human Immunoglobulin for Intravenous Injection Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 65. Japan Human Immunoglobulin for Intravenous Injection Revenue Share by Application (2022-2027)
    Table 66. Japan Human Immunoglobulin for Intravenous Injection Price (US$/Unit) by Application (2022-2027)
    Table 67. North America Human Immunoglobulin for Intravenous Injection Sales by Country (2016-2021) & (K Units)
    Table 68. North America Human Immunoglobulin for Intravenous Injection Sales Market Share by Country (2016-2021)
    Table 69. North America Human Immunoglobulin for Intravenous Injection Revenue by Country (2016-2021) & (US$ Million)
    Table 70. North America Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country (2016-2021)
    Table 71. Asia Pacific Human Immunoglobulin for Intravenous Injection Sales by Region (2016-2021) & (K Units)
    Table 72. Asia Pacific Human Immunoglobulin for Intravenous Injection Sales Market Share by Region (2016-2021)
    Table 73. Asia Pacific Human Immunoglobulin for Intravenous Injection Revenue by Region (2016-2021) & (US$ Million)
    Table 74. Asia Pacific Human Immunoglobulin for Intravenous Injection Revenue Market Share by Region (2016-2021)
    Table 75. Europe Human Immunoglobulin for Intravenous Injection Sales by Country (2016-2021) & (K Units)
    Table 76. Europe Human Immunoglobulin for Intravenous Injection Sales Market Share by Country (2016-2021)
    Table 77. Europe Human Immunoglobulin for Intravenous Injection Revenue by Country (2016-2021) & (US$ Million)
    Table 78. Europe Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country (2016-2021)
    Table 79. Latin America Human Immunoglobulin for Intravenous Injection Sales by Country (2016-2021) & (K Units)
    Table 80. Latin America Human Immunoglobulin for Intravenous Injection Sales Market Share by Country (2016-2021)
    Table 81. Latin Americaa Human Immunoglobulin for Intravenous Injection Revenue by Country (2016-2021) & (US$ Million)
    Table 82. Latin America Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country (2016-2021)
    Table 83. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales by Country (2016-2021) & (K Units)
    Table 84. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales Market Share by Country (2016-2021)
    Table 85. Middle East and Africa Human Immunoglobulin for Intravenous Injection Revenue by Country (2016-2021) & (US$ Million)
    Table 86. Middle East and Africa Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country (2016-2021)
    Table 87. Tiantan Biological Corporation Information
    Table 88. Tiantan Biological Description and Business Overview
    Table 89. Tiantan Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 90. Tiantan Biological Human Immunoglobulin for Intravenous Injection Product
    Table 91. Tiantan Biological Recent Development
    Table 92. Taibang Biological Corporation Information
    Table 93. Taibang Biological Description and Business Overview
    Table 94. Taibang Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 95. Taibang Biological Product
    Table 96. Taibang Biological Recent Development
    Table 97. Shanghai Laishi Corporation Information
    Table 98. Shanghai Laishi Description and Business Overview
    Table 99. Shanghai Laishi Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 100. Shanghai Laishi Product
    Table 101. Shanghai Laishi Recent Development
    Table 102. Hualan Biological Corporation Information
    Table 103. Hualan Biological Description and Business Overview
    Table 104. Hualan Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 105. Hualan Biological Product
    Table 106. Hualan Biological Recent Development
    Table 107. Zhenghua Shenghua Corporation Information
    Table 108. Zhenghua Shenghua Description and Business Overview
    Table 109. Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 110. Zhenghua Shenghua Product
    Table 111. Zhenghua Shenghua Recent Development
    Table 112. Yuanda shuyang Corporation Information
    Table 113. Yuanda shuyang Description and Business Overview
    Table 114. Yuanda shuyang Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 115. Yuanda shuyang Product
    Table 116. Yuanda shuyang Recent Development
    Table 117. Weiguang Biological Corporation Information
    Table 118. Weiguang Biological Description and Business Overview
    Table 119. Weiguang Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 120. Weiguang Biological Product
    Table 121. Weiguang Biological Recent Development
    Table 122. Boya Biological Corporation Information
    Table 123. Boya Biological Description and Business Overview
    Table 124. Boya Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 125. Boya Biological Product
    Table 126. Boya Biological Recent Development
    Table 127. Nanyue Biological Corporation Information
    Table 128. Nanyue Biological Description and Business Overview
    Table 129. Nanyue Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 130. Nanyue Biological Product
    Table 131. Nanyue Biological Recent Development
    Table 132. Paisi feike Corporation Information
    Table 133. Paisi feike Description and Business Overview
    Table 134. Paisi feike Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 135. Paisi feike Product
    Table 136. Paisi feike Recent Development
    Table 137. Kangbao Biological Corporation Information
    Table 138. Kangbao Biological Description and Business Overview
    Table 139. Kangbao Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 140. Kangbao Biological Product
    Table 141. Kangbao Biological Recent Development
    Table 142. Lvshizi Corporation Information
    Table 143. Lvshizi Description and Business Overview
    Table 144. Lvshizi Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 145. Lvshizi Product
    Table 146. Lvshizi Recent Development
    Table 147. Zhongyuan Ruide Corporation Information
    Table 148. Zhongyuan Ruide Description and Business Overview
    Table 149. Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 150. Zhongyuan Ruide Product
    Table 151. Zhongyuan Ruide Recent Development
    Table 152. Human Immunoglobulin for Intravenous Injection Market Trends
    Table 153. Human Immunoglobulin for Intravenous Injection Market Drivers
    Table 154. Human Immunoglobulin for Intravenous Injection Market Challenges
    Table 155. Human Immunoglobulin for Intravenous Injection Market Restraints
    Table 156. Human Immunoglobulin for Intravenous Injection Customers List
    Table 157. Human Immunoglobulin for Intravenous Injection Distributors List
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Immunoglobulin for Intravenous Injection Product Picture
    Figure 2. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Type in 2020 & 2027
    Figure 3. Children Product Picture
    Figure 4. Adult Product Picture
    Figure 5. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Application in 2020 & 2027
    Figure 6. Disease Prevention
    Figure 7. Treatment
    Figure 8. Diagnosis
    Figure 9. Other
    Figure 10. Human Immunoglobulin for Intravenous Injection Report Years Considered
    Figure 11. Global Human Immunoglobulin for Intravenous Injection Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Human Immunoglobulin for Intravenous Injection Market Size 2016-2027 (US$ Million)
    Figure 13. Global Human Immunoglobulin for Intravenous Injection Sales 2016-2027 (K Units)
    Figure 14. Global Human Immunoglobulin for Intravenous Injection Market Size Market Share by Region: 2021 Versus 2027
    Figure 15. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Region (2016-2021)
    Figure 16. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Region in 2020
    Figure 17. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Region (2016-2021)
    Figure 18. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Region in 2020
    Figure 19. Global Human Immunoglobulin for Intravenous Injection Sales Share by Manufacturer in 2020
    Figure 20. The Top 10 and 5 Players Market Share by Human Immunoglobulin for Intravenous Injection Revenue in 2020
    Figure 21. Human Immunoglobulin for Intravenous Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 22. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Type (2016-2021)
    Figure 23. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Type in 2020
    Figure 24. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Type (2016-2021)
    Figure 25. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Type in 2020
    Figure 26. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Application (2016-2021)
    Figure 27. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Application in 2020
    Figure 28. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Application (2016-2021)
    Figure 29. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Application in 2020
    Figure 30. Japan Human Immunoglobulin for Intravenous Injection Sales Growth Rate 2016-2027 (K Units)
    Figure 31. Japan Human Immunoglobulin for Intravenous Injection Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 32. Japan Human Immunoglobulin for Intravenous Injection Market Share in Global Market 2016-2027
    Figure 33. Japan 5 and 10 Largest Human Immunoglobulin for Intravenous Injection Players Market Share by Revenue in Human Immunoglobulin for Intravenous Injection in 2020
    Figure 34. Japan Human Immunoglobulin for Intravenous Injection Revenue Share by Type (2016-2021)
    Figure 35. Japan Human Immunoglobulin for Intravenous Injection Revenue Growth Rate by Type in 2016 & 2020
    Figure 36. Japan Human Immunoglobulin for Intravenous Injection Revenue Share by Application (2016-2021)
    Figure 37. Japan Human Immunoglobulin for Intravenous Injection Revenue Growth Rate by Application in 2016 & 2020
    Figure 38. North America Human Immunoglobulin for Intravenous Injection Sales Growth Rate 2016-2021 (K Units)
    Figure 39. North America Human Immunoglobulin for Intravenous Injection Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 40. North America Human Immunoglobulin for Intravenous Injection Sales Market Share by Country in 2020
    Figure 41. North America Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country in 2020
    Figure 42. U.S. Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 43. U.S. Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Canada Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 45. Canada Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 46. Europe Human Immunoglobulin for Intravenous Injection Sales Growth Rate 2016-2021 (K Units)
    Figure 47. Europe Human Immunoglobulin for Intravenous Injection Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 48. Europe Human Immunoglobulin for Intravenous Injection Sales Market Share by Country in 2020
    Figure 49. Europe Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country in 2020
    Figure 50. Germany Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 51. Germany Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 52. France Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 53. France Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 54. U.K. Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 55. U.K. Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 56. Italy Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 57. Italy Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 58. Russia Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 59. Russia Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 60. Asia Pacific Human Immunoglobulin for Intravenous Injection Sales Growth Rate 2016-2021 (K Units)
    Figure 61. Asia Pacific Human Immunoglobulin for Intravenous Injection Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 62. Asia Pacific Human Immunoglobulin for Intravenous Injection Sales Market Share by Region in 2020
    Figure 63. Asia Pacific Human Immunoglobulin for Intravenous Injection Revenue Market Share by Region in 2020
    Figure 64. China Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 65. China Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 66. Japan Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 67. Japan Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 68. South Korea Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 69. South Korea Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 70. India Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 71. India Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 72. Australia Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 73. Australia Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 74. Taiwan Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 75. Taiwan Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 76. Indonesia Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 77. Indonesia Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 78. Thailand Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 79. Thailand Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 80. Malaysia Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 81. Malaysia Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 82. Philippines Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 83. Philippines Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 84. Vietnam Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 85. Vietnam Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 86. Latin America Human Immunoglobulin for Intravenous Injection Sales Growth Rate 2016-2021 (K Units)
    Figure 87. Latin America Human Immunoglobulin for Intravenous Injection Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 88. Latin America Human Immunoglobulin for Intravenous Injection Sales Market Share by Country in 2020
    Figure 89. Latin America Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country in 2020
    Figure 90. Mexico Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 91. Mexico Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 92. Brazil Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 93. Brazil Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 94. Argentina Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 95. Argentina Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 96. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales Growth Rate 2016-2021 (K Units)
    Figure 97. Middle East and Africa Human Immunoglobulin for Intravenous Injection Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 98. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales Market Share by Country in 2020
    Figure 99. Middle East and Africa Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country in 2020
    Figure 100. Turkey Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 101. Turkey Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 102. Saudi Arabia Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 103. Saudi Arabia Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 104. UAE Human Immunoglobulin for Intravenous Injection Sales Growth Rate (2016-2021) (K Units)
    Figure 105. UAE Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 106. Human Immunoglobulin for Intravenous Injection Value Chain
    Figure 107. Channels of Distribution
    Figure 108. Distributors Profiles
    Figure 109. Bottom-up and Top-down Approaches for This Report
    Figure 110. Data Triangulation
    Figure 111. Key Executives Interviewed